[HTML][HTML] Treatment of coronary in-stent restenosis: a systematic review
L Pleva, P Kukla, O Hlinomaz - Journal of geriatric cardiology: JGC, 2018 - ncbi.nlm.nih.gov
Coronary stent implantation has significantly improved percutaneous coronary intervention
and enabled the management of early complications of plain balloon angioplasty. However …
and enabled the management of early complications of plain balloon angioplasty. However …
Drug-coated balloons in cardiovascular disease: benefits, challenges, and clinical applications
Introduction: Newer-generation drug-eluting stents (DES) are the standard of care for the
treatment of symptomatic coronary artery disease. However, their efficacy is limited by in …
treatment of symptomatic coronary artery disease. However, their efficacy is limited by in …
A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial
J Baan, BE Claessen, KB Dijk, J Vendrik… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The authors sought to evaluate the relative performance of a drug-eluting
balloon (DEB) and a drug-eluting stent (DES) in patients with any (bare-metal or drug …
balloon (DEB) and a drug-eluting stent (DES) in patients with any (bare-metal or drug …
[HTML][HTML] Contemporary management of stent failure: part one
N Pal, J Din, P O'Kane - Interventional Cardiology Review, 2019 - ncbi.nlm.nih.gov
The occurrence of in-stent restenosis (ISR) still remains a daunting challenge in the current
era, despite advancements in coronary intervention technology. The authors explore the …
era, despite advancements in coronary intervention technology. The authors explore the …
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
L Liu, B Liu, J Ren, G Hui, C Qi, J Wang - BMC cardiovascular disorders, 2018 - Springer
Background Drug-eluting balloons (DEB) have significant value for treating coronary artery
disease (CAD). However, the merits of using DEB versus drug-eluting stents (DES) to treat …
disease (CAD). However, the merits of using DEB versus drug-eluting stents (DES) to treat …
Drug coated balloons and their role in bifurcation coronary angioplasty: appraisal of the current evidence and future directions
S Rathore, S Tehrani, D Prvulovic, M Araya… - Expert Review of …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronary Bifurcation lesions are technically more challenging and
Bifurcation percutaneous coronary intervention (PCI) remains a challenge with …
Bifurcation percutaneous coronary intervention (PCI) remains a challenge with …
A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
H Kook, HJ Joo, JH Park, SJ Hong, CW Yu… - BMC Cardiovascular …, 2020 - Springer
Background The current guidelines recommend both repeat stenting and drug-coated
balloons (DCB) for in-stent restenosis (ISR) lesions, if technically feasible. However, real …
balloons (DCB) for in-stent restenosis (ISR) lesions, if technically feasible. However, real …
[HTML][HTML] Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a …
Y Harada, R Colleran, S Pinieck… - …, 2017 - eurointervention.pcronline.com
Aims: We conducted this study to evaluate the efficacy of drug-coated balloon therapy for in-
stent restenosis after coronary bifurcation stenting. Methods and results: Patients who …
stent restenosis after coronary bifurcation stenting. Methods and results: Patients who …
Drug-eluting balloon versus new-generation drug-eluting stent for the treatment of in-stent restenosis: an updated systematic review and meta-analysis
KY Cui, SZ Lyu, M Zhang, XT Song, F Yuan… - Chinese Medical …, 2018 - mednexus.org
Background: Currently, drug-eluting balloon (DEB) appears to be an attractive alternative
option for the treatment of in-stent restenosis (ISR). Nevertheless, the clinical outcomes of …
option for the treatment of in-stent restenosis (ISR). Nevertheless, the clinical outcomes of …
An update on the clinical use of drug-coated balloons in percutaneous coronary interventions
Y Cheng, MB Leon, JF Granada - Expert opinion on drug delivery, 2016 - Taylor & Francis
Introduction: Drug-coated balloons (DCB) promise to deliver anti-proliferative drugs and
prevent restenosis leaving nothing behind. Although, randomized clinical trials have …
prevent restenosis leaving nothing behind. Although, randomized clinical trials have …